Myomo achieved positive cash flow in Q4 2024 with strong gross margins (71.4%) and projects $50-53M revenue for 2025. Read ...

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the ...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and ...